EXELIXIS, INC.

For the period ended Oct 3, 2025. Filed Nov 4, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Oct 3, 2025 · Filed Nov 4, 2025

EXEL$70.58-1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share data)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Revenues:
Net product revenues	$542,930	$478,059	$1,576,227	$1,294,163
Collaboration revenues	54,825	61,483	145,236	307,783
Total revenues	597,755	539,542	1,721,463	1,601,946
Operating expenses:
Cost of goods sold	18,574	17,328	57,216	56,251
Research and development	199,164	222,570	611,753	661,406
Selling, general and administrative	123,661	111,801	395,703	357,800
Impairment of long-lived assets	—	51,672	—	51,672
Restructuring	19,816	96	19,816	33,406
Total operating expenses	361,215	403,467	1,084,488	1,160,535
Income from operations	236,540	136,075	636,975	441,411
Interest income	15,922	18,709	51,787	55,861
Other expenses, net	(49)	(29)	(244)	(405)
Income before income taxes	252,413	154,755	688,518	496,867
Provision for income taxes	58,835	36,782	150,476	115,461
Net income	$193,578	$117,973	$538,042	$381,406
Net income per share:
Basic	$0.72	$0.41	$1.97	$1.31
Diluted	$0.69	$0.40	$1.90	$1.28
Weighted-average common shares outstanding:
Basic	268,421	285,622	273,269	291,865
Diluted	278,535	291,478	283,701	296,994

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.